To learn more, please call our Research Department at (513) 751-2273 or email mhoelle@ohcare.com
| neoadjuvant |
| Study number: |
LUN 186 SCRI |
| Protocol title: |
Phase II Trial of Preoperative Pemetrexed and Carboplatin in Patients with Select Stage IB, II, and III Non-Squamous Non-Small Cell Lung Cancer |
| Status |
Open
|
|
stage IIIB/IV, first-line
|
|
Study number:
|
LUN 183 SCRI
|
|
Protocol title:
|
A Phase II Trial of Carboplatin, Pemetrexed, and Panitumumab in Patients with Advanced Non-Squamous K-ras Wild Type Non-Small Cell Lung Cancer
|
|
Status
|
Open
|
|
|
|
Study number:
|
LUN 196 SCRI
|
|
Protocol title:
|
TOPPS (Trial of Poor Performance Status patients): Randomized Phase II Trial of Pemetrexed vs. Pemetrexe/Bevacizumab vs. Pemetrexed/ Carboplatin/Bevacizumab in Patients with Stage III/IV Non-Small Cell Lung Cancer and ECOG Performance Status 2
|
|
Status
|
Open
|
|
Relapsed/refractory
|
|
Study number:
|
LUN 215 Infinity Pharmaceuticals IPI-504-14
|
|
Protocol title:
|
A Phase 2, Double-Blind, Placebo-Controlled Study of IPI-504 and Docetaxel in Previously Treated Patients with Stage IIIB or IV Non-Small Cell Lung Cancer
|
|
Status
|
Open
|
| Cachexia |
| Study number: |
Medpace/Cachexia Helsinn Therapeutics HT-ANAM-302 |
| Protocol title: |
Anamorelin HCl in the Treatment of Non-Small Cell Lung Cancer-Cachexia (NSCLC-C): A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Phase III Study to Evaluate the Safety and Efficacy of Anamorelin HCl in Patients with NSCLC-C |
| Status |
Open
|
| first line |
| Study number: |
LUN 218 Chorus I2V-MC-CXAC |
| Protocol title: |
A Randomized Phase 2 Study of LY2510924 and Carboplatin/Etoposide versus Carboplatin/Etoposide in Extensive-Stage Small Cell Lung Cancer |
| Status |
Open
|